Physician profile

Landon Fine

Orthopaedic Surgery · Parker, CO

NPI 1134427560

$63,692.46

in general payments reported to CMS, 2019-2025

38 companies · $6,168 in 2025

The $6,168 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

See the full distribution for Orthopaedic Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$12,825.00
Travel and Lodging$6,519.03
Food and Beverage$6,343.65

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Si-Bone, INC. $26,724.05 2019-2024
Stryker Corporation $10,041.63 2019-2025 Pro, Gamma, Axsos
Gemini Mountain Medical, LLC $7,321.42 2019-2025
Arthrex, INC. $6,964.47 2019-2025
Medacta USA, INC. $3,393.54 2021-2025 Primary Shoulder, Reverse Shoulder, Myknee
Pacira Pharmaceuticals Incorporated $2,901.61 2019-2023 Zilretta, Iovera, Exparel
Bone Support INC. $1,325.38 2021-2022
Encore Medical, LP $1,030.11 2019-2022
Zimmer Biomet Holdings, INC. $1,025.59 2022-2025 Tricera Handpiece, Comprehensive Shoulder System, Rosa
Smith+Nephew, INC. $410.48 2021-2025 Bioinductive Implant With Arthroscopic Delivery System - Medium, Evos, Taylor Spatial Frame
Globus Medical, INC. $289.13 2023-2024 Proximal Tibia Plate, Distal Femur Plate System, Tibial Nail
Becton, Dickinson and Company $255.55 2022
Skeletal Dynamics INC $248.02 2023-2024 Align, Implate, Ijs
Ucb, INC. $220.35 2019-2023
Fx Shoulder Solutions, INC $192.19 2024-2025
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Radius Health, INC. $159.57 2019-2025 Tymlos
Acell, INC. $139.50 2019
Nuvasive Specialized Orthopedics, INC. $136.58 2020
Amgen INC. $128.59 2019-2025 Prolia, Evenity
Acumed LLC $127.23 2019-2024 Acumed
Gemini Medical LLC $113.87 2021
Baxter Healthcare $89.99 2021-2025
Integra Lifesciences Corporation $55.01 2021-2025 Integra, Primatrix, Integra Dermal Regeneration Template
Bioventus LLC $43.50 2024-2025 Xcell, Durolane
Organogenesis INC. $40.38 2022-2025 Puraply Wound Matrix
Arthrosurface Incorporated $40.00 2019
Biocomposites INC $36.03 2019-2024
Anika Therapeutics, INC. $30.45 2024 Revomotion, Ovo Motion
Ossur Americas, INC. $29.11 2024
Davol INC. $28.51 2022
Convatec INC. $23.16 2021
Acera Surgical, INC. $21.29 2023 Restrata Wound Matrix
Aroa Biosurgery Incorporated $20.74 2024
Depuy Synthes Sales INC. $20.13 2020
Djo, LLC $17.34 2020
Kerecis Limited $17.09 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Heraeus Medical, LLC. $17.07 2022
Illuminoss Medical, INC. $13.80 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Landon Fine

$63,692.46

in general payments reported 2019-2025

Years
2019-2025
Top company
Si-Bone, INC.
Context
The $6,168 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).

https://glasscript.com/doctor/2792617/landon-fine

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.